
Latest Annual Report
Sedana Medical reached an important milestone in 2021, when the pharmaceutical product Sedaconda (isoflurane), and consequently inhaled sedation therapy, received European market approval.
Here you get access to interim and annual reports as well as presentations related to our reports and financial results.
Sedana Medical reached an important milestone in 2021, when the pharmaceutical product Sedaconda (isoflurane), and consequently inhaled sedation therapy, received European market approval.